AAAAAA

   
Results: 1-23 |
Results: 23
CONSTANT DENATURANT GEL-ELECTROPHORESIS (CDGE) IN BRCA1 MUTATION SCREENING
Authors: ANDERSEN TI EIKEN HG COUCH F KAADA G SKREDE M JOHNSEN H ALOYSIUS TA TVEIT KM TRANEBJAERG L DORUM A MOLLER P WEBER BL BORRESENDALE AL
Citation: Ti. Andersen et al., CONSTANT DENATURANT GEL-ELECTROPHORESIS (CDGE) IN BRCA1 MUTATION SCREENING, Human mutation, 11(2), 1998, pp. 166-174
SINGLE TUBE MULTIPLEX POLYMERASE-CHAIN-REACTION GENOTYPE ANALYSIS OF GSTM1, GSTT1 AND GSTP1 - RELATION OF GENOTYPES TO TP53 TUMOR STATUS AND CLINICOPATHOLOGICAL VARIABLES IN BREAST-CANCER PATIENTS
Authors: KRISTENSEN VN ANDERSEN TI ERIKSTEIN B GEITVIK G SKOVLUND E NESLAND JM BORRESENDALE AL
Citation: Vn. Kristensen et al., SINGLE TUBE MULTIPLEX POLYMERASE-CHAIN-REACTION GENOTYPE ANALYSIS OF GSTM1, GSTT1 AND GSTP1 - RELATION OF GENOTYPES TO TP53 TUMOR STATUS AND CLINICOPATHOLOGICAL VARIABLES IN BREAST-CANCER PATIENTS, Pharmacogenetics, 8(5), 1998, pp. 441-447
A RARE CYP19 (AROMATASE) VARIANT MAY INCREASE THE RISK OF BREAST-CANCER
Authors: KRISTENSEN VN ANDERSEN TI LINDBLOM A ERIKSTEIN B MAGNUS P BORRESENDALE AL
Citation: Vn. Kristensen et al., A RARE CYP19 (AROMATASE) VARIANT MAY INCREASE THE RISK OF BREAST-CANCER, Pharmacogenetics, 8(1), 1998, pp. 43-48
MUTATION SCREENING OF BRCA1 USING PTT AND LOH ANALYSIS AT 17Q21 IN BREAST CARCINOMAS FROM FAMILIAL AND NONFAMILIAL CASES
Authors: SORLIE T ANDERSEN TI BUKHOLM I BORRESENDALE AL
Citation: T. Sorlie et al., MUTATION SCREENING OF BRCA1 USING PTT AND LOH ANALYSIS AT 17Q21 IN BREAST CARCINOMAS FROM FAMILIAL AND NONFAMILIAL CASES, Breast cancer research and treatment, 48(3), 1998, pp. 259-264
CONSORTIUM STUDY ON 1280 BREAST CARCINOMAS - ALLELIC LOSS ON CHROMOSOME-17 TARGETS SUBREGIONS ASSOCIATED WITH FAMILY HISTORY AND CLINICAL-PARAMETERS
Authors: PHELAN CM BORG A CUNY M CRICHTON DN BALDERSSON T ANDERSEN TI CALIGO MA LIDEREAU R LINDBLOM A SEITZ S KELSELL D HAMANN K RIO P THORLACIUS S PAPP J OLAH E PONDER B BIGNON YJ SCHERNECK S BARKARDOTTIR R BORRESENDALE AL EYFJORD J THEILLET C THOMPSON AM DEVILEE P LARSSON C
Citation: Cm. Phelan et al., CONSORTIUM STUDY ON 1280 BREAST CARCINOMAS - ALLELIC LOSS ON CHROMOSOME-17 TARGETS SUBREGIONS ASSOCIATED WITH FAMILY HISTORY AND CLINICAL-PARAMETERS, Cancer research, 58(5), 1998, pp. 1004-1012
THE APC GENE I1307K VARIANT IS RARE IN NORWEGIAN PATIENTS WITH FAMILIAL AND SPORADIC COLORECTAL OR BREAST-CANCER
Authors: LOTHE RA HEKTOEN M JOHNSEN H MELING GI ANDERSEN TI ROGNUM TO LINDBLOM A BORRESENDALE AL
Citation: Ra. Lothe et al., THE APC GENE I1307K VARIANT IS RARE IN NORWEGIAN PATIENTS WITH FAMILIAL AND SPORADIC COLORECTAL OR BREAST-CANCER, Cancer research, 58(14), 1998, pp. 2923-2924
SCREENING FOR ESR MUTATIONS IN BREAST AND OVARIAN-CANCER PATIENTS
Authors: ANDERSEN TI WOOSTER R LAAKE K COLLINS N WARREN W SKREDE M EELES R TVEIT KM JOHNSTON SRD DOWSETT M OLSEN AO MOLLER P STRATTON MR BORRESENDALE AL
Citation: Ti. Andersen et al., SCREENING FOR ESR MUTATIONS IN BREAST AND OVARIAN-CANCER PATIENTS, Human mutation, 9(6), 1997, pp. 531-536
LOSS OF HETEROZYGOSITY AT 11Q23.1 IN BREAST CARCINOMAS - INDICATION FOR INVOLVEMENT OF A GENE DISTAL AND CLOSE TO ATM
Authors: LAAKE K ODEGARD A ANDERSEN TI BUKHOLM IK KARESEN R NESLAND JM OTTESTAD L SHILOH Y BORRESENDALE AL
Citation: K. Laake et al., LOSS OF HETEROZYGOSITY AT 11Q23.1 IN BREAST CARCINOMAS - INDICATION FOR INVOLVEMENT OF A GENE DISTAL AND CLOSE TO ATM, Genes, chromosomes & cancer, 18(3), 1997, pp. 175-180
LOSS OF HETEROZYGOSITY AT 7Q31 IN BREAST-CANCER - RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY-GROUP
Authors: DEVILEE P HERMANS J EYFJORD J BORRESEN AL LIDEREAU R SOBOL H BORG A CLETONJANSEN AM OLAH E COHEN B SCHERNECK S HAMANN U PETERLIN B CALIGO M BIGNON YL MAUGARD C ANDERSEN TI ODEGAND AEM BIECHE I BIRNBAUM D CORNELISSE CJ SZTAN M STEEL MR SEITZ S LOGAR N GOLOUH R GHIMENTI C BRUELLE S JOALLAND MP
Citation: P. Devilee et al., LOSS OF HETEROZYGOSITY AT 7Q31 IN BREAST-CANCER - RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY-GROUP, Genes, chromosomes & cancer, 18(3), 1997, pp. 193-199
POLYMORPHISMS IN THE CYP19 (AROMATASE) GENE WITH PUTATIVE ROLE IN THEREGULATION OF GENE-EXPRESSION
Authors: NEDELCHEVA V ANDERSEN TI LINDBLOM A KRISTENSEN T NESLAND JM OLSEN A BORRESENDALE AL
Citation: V. Nedelcheva et al., POLYMORPHISMS IN THE CYP19 (AROMATASE) GENE WITH PUTATIVE ROLE IN THEREGULATION OF GENE-EXPRESSION, The FASEB journal, 11(9), 1997, pp. 157-157
A SCREENING FOR BRCA1 MUTATIONS IN BREAST AND BREAST-OVARIAN CANCER FAMILIES FROM THE STOCKHOLM REGION
Authors: ZELADAHEDMAN M ARVER BW CLARO A CHEN JD WERELIUS B KOK H SANDELIN K HAKANSSON S ANDERSEN TI BORG A DALE ALB LINDBLOM A
Citation: M. Zeladahedman et al., A SCREENING FOR BRCA1 MUTATIONS IN BREAST AND BREAST-OVARIAN CANCER FAMILIES FROM THE STOCKHOLM REGION, Cancer research, 57(12), 1997, pp. 2474-2477
GENETIC-HETEROGENEITY IN BREAST-CANCER SUSCEPTIBILITY
Authors: ANDERSEN TI
Citation: Ti. Andersen, GENETIC-HETEROGENEITY IN BREAST-CANCER SUSCEPTIBILITY, Acta oncologica, 35(4), 1996, pp. 407-410
TP53 ALTERATIONS IN ATYPICAL DUCTAL HYPERPLASIA AND DUCTAL CARCINOMA IN-SITU OF THE BREAST
Authors: CHITEMERERE M ANDERSEN TI HOLM R KARLSEN F BORRESEN AL NESLAND JM
Citation: M. Chitemerere et al., TP53 ALTERATIONS IN ATYPICAL DUCTAL HYPERPLASIA AND DUCTAL CARCINOMA IN-SITU OF THE BREAST, Breast cancer research and treatment, 41(2), 1996, pp. 103-109
ASSOCIATION STUDIES OF ESTROGEN-RECEPTOR POLYMORPHISMS IN A NORWEGIANTESTICULAR CANCER POPULATION
Authors: HEIMDAL K ANDERSEN TI SKREDE M FOSSA SD BERG K BORRESEN AL
Citation: K. Heimdal et al., ASSOCIATION STUDIES OF ESTROGEN-RECEPTOR POLYMORPHISMS IN A NORWEGIANTESTICULAR CANCER POPULATION, Cancer epidemiology, biomarkers & prevention, 4(2), 1995, pp. 123-126
ALTERATIONS OF THE TP53 GENE AS A POTENTIAL PROGNOSTIC MARKER IN BREAST CARCINOMAS - ADVANTAGES OF USING CONSTANT DENATURANT GEL-ELECTROPHORESIS IN MUTATION DETECTION
Authors: ANDERSEN TI BORRESEN AL
Citation: Ti. Andersen et Al. Borresen, ALTERATIONS OF THE TP53 GENE AS A POTENTIAL PROGNOSTIC MARKER IN BREAST CARCINOMAS - ADVANTAGES OF USING CONSTANT DENATURANT GEL-ELECTROPHORESIS IN MUTATION DETECTION, Diagnostic molecular pathology, 4(3), 1995, pp. 203-211
TP53 MUTATIONS AND BREAST-CANCER PROGNOSIS - PARTICULARLY POOR SURVIVAL RATES FOR CASES WITH MUTATIONS IN THE ZINC-BINDING DOMAINS
Authors: BORRESEN AL ANDERSEN TI EYFJORD JE CORNELIS RS THORLACIUS S BORG A JOHANSSON U THEILLET C SCHERNECK S HARTMAN S CORNELISSE CJ HOVIG E DEVILEE P
Citation: Al. Borresen et al., TP53 MUTATIONS AND BREAST-CANCER PROGNOSIS - PARTICULARLY POOR SURVIVAL RATES FOR CASES WITH MUTATIONS IN THE ZINC-BINDING DOMAINS, Genes, chromosomes & cancer, 14(1), 1995, pp. 71-75
DETECTION OF C-ERBB-2 RELATED PROTEIN IN SERA FROM BREAST-CANCER PATIENTS - RELATIONSHIP TO ERBB2 GENE AMPLIFICATION AND C-ERBB-2 PROTEIN OVEREXPRESSION IN TUMOR
Authors: ANDERSEN TI PAUS E NESLAND JM MCKENZIE SJ BORRESEN AL
Citation: Ti. Andersen et al., DETECTION OF C-ERBB-2 RELATED PROTEIN IN SERA FROM BREAST-CANCER PATIENTS - RELATIONSHIP TO ERBB2 GENE AMPLIFICATION AND C-ERBB-2 PROTEIN OVEREXPRESSION IN TUMOR, Acta oncologica, 34(4), 1995, pp. 499-504
ESTROGEN-RECEPTOR (ESR) POLYMORPHISMS AND BREAST-CANCER SUSCEPTIBILITY
Authors: ANDERSEN TI HEIMDAL KR SKREDE M TVEIT K BERG K BORRESEN AL
Citation: Ti. Andersen et al., ESTROGEN-RECEPTOR (ESR) POLYMORPHISMS AND BREAST-CANCER SUSCEPTIBILITY, Human genetics, 94(6), 1994, pp. 665-670
GENETIC ALTERATIONS OF CHROMOSOME-17 IN HUMAN BREAST-CARCINOMA STUDIED BY FLUORESCENCE IN-SITU HYBRIDIZATION AND MOLECULAR DNA TECHNIQUES
Authors: ROSENBERG C ANDERSEN TI NESLAND JM LIER ME BROGGER A BORRESEN AL
Citation: C. Rosenberg et al., GENETIC ALTERATIONS OF CHROMOSOME-17 IN HUMAN BREAST-CARCINOMA STUDIED BY FLUORESCENCE IN-SITU HYBRIDIZATION AND MOLECULAR DNA TECHNIQUES, Cancer genetics and cytogenetics, 75(1), 1994, pp. 1-5
GENOME SCANNING OF BREAST CANCERS BY 2-DIMENSIONAL DNA TYPING
Authors: VERWEST AM DELEEUW WJF MOLIJN AC ANDERSEN TI BORRESEN AL MULLAART E UITTERLINDEN AG VIJG J
Citation: Am. Verwest et al., GENOME SCANNING OF BREAST CANCERS BY 2-DIMENSIONAL DNA TYPING, British Journal of Cancer, 69(1), 1994, pp. 84-92
AMPLIFICATION OF C-ERBB-2, INT-2 AND C-MYC GENES IN NODE-NEGATIVE BREAST CARCINOMAS - RELATIONSHIP TO PROGNOSIS
Authors: OTTESTAD L ANDERSEN TI NESLAND JM SKREDE M TVEIT KM NUSTAD K BORRESEN AL
Citation: L. Ottestad et al., AMPLIFICATION OF C-ERBB-2, INT-2 AND C-MYC GENES IN NODE-NEGATIVE BREAST CARCINOMAS - RELATIONSHIP TO PROGNOSIS, Acta oncologica, 32(3), 1993, pp. 289-294
GENOMIC INSTABILITY IN COLORECTAL-CANCER - RELATIONSHIP TO CLINICOPATHOLOGICAL VARIABLES AND FAMILY HISTORY
Authors: LOTHE RA PELTOMAKI P MELING GI AALTONEN LA NYSTROMLAHTI M PYLKKANEN L HEIMDAL K ANDERSEN TI MOLLER P ROGNUM TO FOSSA SD HALDORSEN T LANGMARK F BROGGER A DELACHAPELLE A BORRESEN AL
Citation: Ra. Lothe et al., GENOMIC INSTABILITY IN COLORECTAL-CANCER - RELATIONSHIP TO CLINICOPATHOLOGICAL VARIABLES AND FAMILY HISTORY, Cancer research, 53(24), 1993, pp. 5849-5852
PROGNOSTIC-SIGNIFICANCE OF TP53 ALTERATIONS IN BREAST-CARCINOMA
Authors: ANDERSEN TI HOLM R NESLAND JM HEIMDAL KR OTTESTAD L BORRESEN AL
Citation: Ti. Andersen et al., PROGNOSTIC-SIGNIFICANCE OF TP53 ALTERATIONS IN BREAST-CARCINOMA, British Journal of Cancer, 68(3), 1993, pp. 540-548
Risultati: 1-23 |